TY  - GEN
AU  - Karlsson,C
AU  - Norin,S
AU  - Kimby,E
AU  - Sander,B
AU  - Porwit Macdonald,A
AU  - Nilsson,B
AU  - Johansson,E
AU  - Mellstedt,H
AU  - Lundin,J
AU  - Osterborg,A
TI  - Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
SN  - 0887-6924
PY  - 2007///0920
KW  - Adult
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Infections
KW  - etiology
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - complications
KW  - Male
KW  - Middle Aged
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.leu.2404435
ER  -